Invasive fungal infection in a child with Ewing’s sarcoma Case report

Article Sidebar

PDF


Published: Jan 23, 2016
DOI: https://doi.org/10.5604/01.3001.0009.7393
Keywords:
invasive fungal infection, Candida glabtrata, Ewing's sarcoma, children

Main Article Content

Elżbieta Adamkiewicz-Drożyńska
Department and Clinic of Paediatrics, Haematology and Oncology, Medical University of Gdansk, Poland
Ewa Bień
Department and Clinic of Paediatrics, Haematology and Oncology, Medical University of Gdansk, Poland
Anna Płoszyńska
Department and Clinic of Paediatrics, Haematology and Oncology, Medical University of Gdansk, Poland

Abstract

Invasive fungal infection (IFI) in patients with malignant solid tumours is rare, but it highly increases the risk of cancer recurrence because of prolonged discontinuation of cancer treatment. This paper presents a case of IFI induced by Candida glabrata in a 14-year-old girl with advanced Ewing’s sarcoma and metastases to the bone marrow. She was intensively treated with chemotherapy (CWS, CEVAIE, EWING 2008 + VIDE) and radiotherapy. As the treatment was ineffective, the tumour was surgically removed from the sacrum, and VAI chemotherapy was administered. Due to the symptoms of infection, antifungal treatment was initiated with caspofungin, followed by prophylaxis with posaconazole. In terms of anti-cancer treatment, the patient received megatherapy with auto-HSCT. Signs of infection and gastrotoxic complications developed, which is why broad-spectrum antibiotics and amphotericin B lipid complex were administered. Even so, a multisystem IFI appeared, causing the patient’s death. In multidrug chemotherapy with extended periods of agranulocytosis, primary prevention should be considered, similar to the one offered to patients with haematological malignancies.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
1.
Adamkiewicz-Drożyńska E, Bień E, Płoszyńska A. Invasive fungal infection in a child with Ewing’s sarcoma. OncoReview [Internet]. 2016Jan.23 [cited 2024May5];7(1(25):38-3. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/441
Issue
Vol 7 No 1(25) (2017)
Section
SUPPORTIVE CARE IN ONCOLOGY
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Dzierżanowska D, Gil L, Jakubas B et al. Epidemiologia i diagnostyka mikrobiologiczna inwazyjnej choroby grzybiczej. Post Nauk Med 2015; 6: 403-409.
2. Kałwak K. Profilaktyka zakażeń grzybiczych u dzieci poddawanych transplantacjom komórek hematopoetycznych. Acta Hematol Pol 2014; 45(4): 354-359.
3. Stefaniak MJ. Postępowanie u chorych ze schorzeniami onkohematologicznymi wymagających terapeutycznego zastosowania leków przeciwgrzybiczych. In: Kowalczyk J.R. (ed). Onkohematologia dziecięca – co nowego? Cornetis, Wrocław 2009: 84-116.
4. Choi YB, Yi ES, Kang JM et al. Infectious Complications during Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Children with High-Risk or Recurrent Solid Tumors. PLoS ONE 2016; 11(9): e0162178. https://doi.org/10.1371/journal.pone.0162178.
5. Styczyński J.: Leczenie zakażeń u dzieci ze schorzeniami onkohematologicznymi. Post Nauk Med 2014; 4: 292-297.
6. Science M, Robinson PD, MacDonald T et al. Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients. Pediatr Blood Cancer 2014; 61(3): 393-400.
7. Stieglitz E, Hsiang MS, Simko JP et al. Pulmonary coccidiomycosis masquerading as refractory metastatic Ewing sarcoma. J Pediatr Hematol Oncol 2014; 36(1): 57-60.
8. Prażyńska M, Gospodarek-Komkowska E. Leczenie wybranych postaci kandydozy zgodnie z aktualnymi wytycznymi Amerykańskiego Towarzystwa Chorób Zakaźnych (IDSA 2016). Zakażenia 2016; 16(4): 41-52.
9. Devrim I, Yaman Y, Demirağ B et al. A single center’s experience with Candida parapsilosis related long-term central venous access device infections: the port removal decision and its outcomes. Pediatr Hematol Oncol 2014; 31(5): 435-441.
10. Cornely OA, Gachot B, Akan H et al. Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Infectious Diseases Group. Clin Infect Dis 2015; 61(3): 324-331.
11. Rutkowski P, Mazurkiewicz T, Fijuth J et al. Mięsaki kości. In: Rutkowski P, Mazurkiewicz T (ed). Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych – 2013. Volume 2. Via Medica, Gdańsk 2013: 440-456.
12. Warady BA, Bashir M, Donaldson A. Fungal peritonitis in children receiving peritoneal dialysis: A report of NAPRTCS. Kidney Int 2000; 58: 384-389.
13. Biliński P, Seferyńska I, Warzocha K. Diagnostyka i leczenie układowych zakażeń grzybiczych w onkohematologii. Onkol Prakt Klin 2008; 4(1): 15-24.
14. Glockner A, Cornely OA. Candida glabrata – unique features and challenges in the clinical management of invasive infections. Mycoses 2015; 58(8): 445-450.
15. Tibúrcio FR, de Sá Rodrigues KE, Vasconcelos HM et al. Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report. BMC Pediatr 2015; 3(15): 108-112.